Intranasal Esketamine for Patients at Imminent Risk for Suicide

September 6, 2018

Douglas Grover, MD PGY2

David Seigler, MD

Target Audience

This activity was developed for physicians along with nurses and ancillary staff.

Learning Objectives

At the end of this presentation, participants should be better able to:

  • Explain the basic pharmacology and uses of esketamine
  • Discuss the Montgomery-Asberg Depression Rating Scale (MADRS)
  • Analyze the potential efficacy and clinical relevance for the use of intranasal esketamine for depression
  • Assess limitations and challenges for the use of intranasal esketamine

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
Course opens: 
09/06/2018
Course expires: 
04/30/2019
Event starts: 
09/06/2018 - 12:00pm
Event ends: 
09/06/2018 - 1:30pm
Cost:
$0.00
Rating: 
0
University of California School of Medicine at Riverside
Riverside, CA 92521
United States

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or register to take this course.